Replimune Group, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a REPL research report →
Companywww.replimune.com
Replimune Group, Inc. , a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer.
- CEO
- Sushil Patel
- IPO
- 2018
- Employees
- 479
- HQ
- Woburn, MA, US
Price Chart
Valuation
- Market Cap
- $426.07M
- P/E
- -1.51
- P/S
- 0.00
- P/B
- 2.26
- EV/EBITDA
- -1.22
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -102.69%
- ROIC
- -113.17%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-247,297,000 · -14.60%
- EPS
- $-3.07 · 5.25%
- Op Income
- $-261,627,000
- FCF YoY
- -4.09%
Performance & Tape
- 52W High
- $13.24
- 52W Low
- $1.50
- 50D MA
- $5.00
- 200D MA
- $6.79
- Beta
- 0.12
- Avg Volume
- 6.02M
Get TickerSpark's AI analysis on REPL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 18, 26 | Patel Sushil | sell | 37,324 |
| May 18, 26 | Hill Emily Luisa | sell | 7,812 |
| Apr 1, 26 | BAKER BROS. ADVISORS LP | other | 44,500 |
| Apr 1, 26 | Sarchi Christopher | other | 50,000 |
| Apr 1, 26 | Sarchi Christopher | other | 75,000 |
| Apr 1, 26 | Astley-Sparke Philip | other | 50,000 |
| Apr 1, 26 | Astley-Sparke Philip | other | 75,000 |
| Apr 1, 26 | Oliger Christy J. | other | 44,500 |
| Apr 1, 26 | Xynos Konstantinos | other | 50,000 |
| Apr 1, 26 | Xynos Konstantinos | other | 75,000 |
Our REPL Coverage
We haven't published any research on REPL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate REPL Report →